Search for Articles
Jan 26, 2023
Dec 22, 2022
Rocket Pharmaceuticals Provides Update on Anticipated Registration Path for RP-A501 in Danon Disease Following End-of-Phase 1 FDA Meeting
CRANBURY, N.J.--(BUSINESS WIRE)--Dec. 22, 2022-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company...
Dec 21, 2022
Comanche Biopharma Announces Appointment of Allison August, M.D., as Chief Medical Officer
Dec 8, 2022
Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease
Dec 1, 2022
Rocket Pharmaceuticals Completes Acquisition of Renovacor
CRANBURY, N.J.--(BUSINESS WIRE)--Dec. 1, 2022-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company...
Nov 30, 2022
Broadview Ventures Appoints Cardiovascular Leader and Biotech Executive Michael Mendelsohn, MD to its Strategic Advisory Board
BOSTON – November 30, 2022 – Broadview Ventures, a mission-driven, cardiovascular health-focused investment organization, today announced...